CAS: 140926-75-6
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
1,2-Ethanediamine, N1,N2-bis(7-chloro-4-quinolinyl)- REF: IN-DA001FMWCAS: 140926-75-6 | 99% | To inquire | Tue 10 Dec 24 | |
RE-640 REF: TM-T3188CAS: 140926-75-6 | 99.87% - 99.91% | 34.00 €~724.00 € | Tue 17 Dec 24 | |
NSC 5844 REF: 3D-QFA92675CAS: 140926-75-6 | Min. 95% | To inquire | Tue 21 Jan 25 |
1,2-Ethanediamine, N1,N2-bis(7-chloro-4-quinolinyl)-
CAS:140926-75-6
Formula:
C20H16Cl2N4
Purity:
99%
Molecular weight:
383.2738
Ref: IN-DA001FMW
1mg | 94.00 € | ||
2mg | 123.00 € | ||
5mg | 168.00 € | ||
10mg | 223.00 € | ||
25mg | 321.00 € | ||
50mg | 622.00 € | ||
100mg | To inquire | ||
200mg | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
RE-640
CAS:140926-75-6
NSC-5844 (RE-640) (RE640) is a bisquinoline compound with C-C chemokine receptor type 1 (CCR1)-agonistic activities.
Formula:
C20H16Cl2N4
Purity:
99.87% - 99.91%
Color and Shape:
Solid
Molecular weight:
383.27
Ref: TM-T3188
5mg | 34.00 € | ||
10mg | 56.00 € | ||
25mg | 93.00 € | ||
50mg | 124.00 € | ||
100mg | 177.00 € | ||
200mg | 266.00 € |
Estimated delivery in United States, on Tuesday 17 Dec 2024
NSC 5844
CAS:140926-75-6
NSC 5844 is a therapeutic inhibitor of angiogenesis. It inhibits the growth of new blood …
Formula:
C20H16Cl2N4
Purity:
Min. 95%
Molecular weight:
383.27 g/mol
Ref: 3D-QFA92675
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 21 Jan 2025